Guest: ACCC President Randall A. Oyer, MD
Medical Director, Oncology Program
Penn Medicine Lancaster General Health
The coronavirus (COVID-19) impacts all facets of healthcare, including the administration of—and patient access to—clinical trials. COVID-19 poses a particularly significant challenge for oncology clinical trials, as investigational approaches are often considered standard of care for many disease types.
In this webcast, ACCC President Randall A. Oyer, MD, discusses the landscape of oncology clinical trials during the COVID-19 pandemic. Topics include:
View On-Demand Replay Download Slides